|
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
|
|
|
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
antispasmodic drug
A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder.
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
|
|
|
3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[2.2.2]octane bromide
|
|
(±)-3-hydroxy-1-methylquinuclidinium bromide benzilate
|
ChemIDplus
|
|
1-methyl-3-(benziloyloxy)quinuclidinium bromide
|
ChemIDplus
|
|
3-(2,2-diphenyl-2-hydroxyethanoyloxy)-quinuclidinium bromide
|
ChemIDplus
|
|
3-(benziloyloxy)-1-methylquinuclidinium bromide
|
ChemIDplus
|
|
3-hydroxy-1-methylquinuclidinium bromide benzilate
|
ChemIDplus
|
|
quinuclidinol methylbromide, benzilate
|
ChemIDplus
|
23-
